John A. Kollins - Jun 3, 2022 Form 4 Insider Report for Satsuma Pharmaceuticals, Inc. (STSA)

Role
President and CEO, Director
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for John A. Kollins
Stock symbol
STSA
Transactions as of
Jun 3, 2022
Transactions value $
$0
Form type
4
Date filed
6/7/2022, 05:38 PM
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STSA Stock Option (Right to Buy) Award $0 +505K $0.00 505K Jun 3, 2022 Common Stock 505K $3.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty Five Percent (25%) of the shares subject to the option vest one year measured from June 3, 2022 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.